<DOC>
	<DOCNO>NCT00088270</DOCNO>
	<brief_summary>Multi-center , randomize Phase II study evaluate efficacy safety OSI-7904Lversus 5 FU/LV biliary tract cancer .</brief_summary>
	<brief_title>A Study OSI-7904L Versus 5-FU/LV Treatment Patients With Biliary Tract Cancer</brief_title>
	<detailed_description />
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Documented locally advanced metastatic adenocarcinoma biliary tract ; Adequate bone marrow , hepatic renal function ; Bilirubin &lt; = 1.5 time upper limit normal ; Age 18 year old ; Predicted life expectancy 12 week ; Prior surgery radiation therapy permit provided patient recover adequately ; At least 1 target lesion &gt; = 20 mm ( &gt; = 10 mm spiral CTscan ) ; ECOG Performance Status 02 ; No prior chemotherapy locally advanced metastatic disease . Adjuvant/neoadjuvant permit therapy complete least 12 month prior study entry ; Concurrent anticancer therapy study ; History malignancy within past 3 year except basal squamous cell carcinoma situ cervical cancer ; Symptomatic brain metastasis stable require radiation past 28 day ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2004</verification_date>
</DOC>